← Open Payments lookup

KETAKI VAIDHYANATHAN: Open Payments

NPI 1992904445 · MONTCLAIR, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,421 in 89 payments from 11 companies in 2025. Trend: 2023 $436 · 2024 $622 · 2025 $1,421

Food & beverage: $1,316Education: $104
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.16$310
Alkermes, Inc.11$210
Otsuka America Pharmaceutical, Inc.14$199
Janssen Pharmaceuticals, Inc18$164
Lundbeck LLC9$160
E.R. Squibb & Sons, L.L.C.9$155
Neurocrine BioSciences, Inc.4$81
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$63
Axsome Therapeutics, Inc.3$51
Validus Pharmaceuticals LLC1$14

Products named: ABILIFY ASIMTUFII, ARISTADA, INVEGA SUSTENNA, COBENFY, AUSTEDO XR, INGREZZA, UZEDY, CAPLYTA.

Industry payments across NJ — which companies pay providers there.